The Nonsteroidal Anti-Inflammatory Drug Ketorolac Alters the Small Intestinal Microbiota and Bile Acids Without Inducing Intestinal Damage or Delaying Peristalsis in the RatBarbara Hutka, Zoltán Zádori|Frontiers in Pharmacology|2021Cited by 14
Chronic treatment with rofecoxib but not ischemic preconditioning of the myocardium ameliorates early intestinal damage following cardiac ischemia/reperfusion injury in ratsSzilvia B. László, Zoltán Zádori|Biochemical Pharmacology|2020Cited by 11
A dual role of lysophosphatidic acid type 2 receptor (LPAR2) in nonsteroidal anti-inflammatory drug-induced mouse enteropathyBarbara Hutka, Zoltán Zádori|Acta Pharmacologica Sinica|2023Cited by 5